Arka Prava Bhattacharya, MD
Family Practice · Yuba City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 6 years
- Graduated 2020
Offices
1 location · Peach Tree Healthcare · 32 clinicians in this group
Looking this up.
Hospitals listed: 057448 · Adventist Health and Rideout. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhattacharya’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health and RideoutMarysville, CAAcute Care Hospital · Government - Federal · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 2 of 5 · 52% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.185, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.278, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health and Rideout
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.278 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.39 (0.38 to 2.39) · 1,014 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.57 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 201.11 (154.04 to 248.18) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.9 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 229 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 255 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.1 · 713 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 660 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.2 · 265 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 2,347 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 7,148 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.09 to 0.48) · 7,390 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.77 (1.69 to 5.85) · 1,259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.23) · 239 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.51 (1.01 to 4.02) · 1,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.42 (0 to 15.26) · 241 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.32 (1.3 to 9.35) · 220 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.48 to 3.42) · 187 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.42 (0 to 1.02) · 6,712 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.246 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.644 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.447 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 211 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 694 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 38.3 · 232 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33.9 · 801 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43 · 665 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 617 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.6 to 8.9) · 213 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.9 (9.1 to 15.5) · 213 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.5) · 167 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.5) · 316 cases | No different | Jan 2024 – Dec 2024 |
What patients said (559 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 52% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Drugs they prescribed that Part D paid
$66,079
Pharmacies billed $66,079 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 645) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
530 generic and fewer than 11 brand-name prescriptions · $66,079 in drug cost · 32 antibiotic prescriptions to 29 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 19 | $10,836 | $570 |
| Eliquis | 12 | $8,732 | $728 |
| Atorvastatin | 52 | $589 | $11 |
| Losartan | 53 | $386 | $7 |
| Levothyroxine | 30 | $357 | $12 |
See all 16 drugs
| Jardiance | 19 | $10,836 | $570 |
| Eliquis | 12 | $8,732 | $728 |
| Atorvastatin | 52 | $589 | $11 |
| Losartan | 53 | $386 | $7 |
| Levothyroxine | 30 | $357 | $12 |
| Fluticasone Propionate | 20 | $257 | $13 |
| Metformin Hcl Er | 19 | $229 | $12 |
| Metoprolol | 13 | $194 | $15 |
| Amlodipine Besylate | 28 | $152 | $5 |
| Lisinopril | 14 | $141 | $10 |
| Citalopram Hbr | 15 | $113 | $8 |
| Alendronate | 16 | $93 | $6 |
| Furosemide | 22 | $82 | $4 |
| Amoxicillin-Clavulanate Potass | 11 | $68 | $6 |
| Prednisone | 23 | $52 | $2 |
| Famotidine | 11 | $32 | $3 |
Year by year
| 2024 | 645 | 146 | 0% (0) | None | $66,079 |
| 2023 | 483 | 160 | 0% (0) | None | $27,526 |
| 2022 | 137 | 60 | 0% (0) | None | $3,293 |
| 2021 | 17 | None | 0% (0) | None | $1,637 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Levothyroxine | 19 | $383 | $20 |
| Losartan | 27 | $280 | $10 |
| Atorvastatin | 22 | $188 | $9 |
| Fluticasone Propionate | 19 | $186 | $10 |
| Amoxicillin-Clavulanate Potass | 16 | $148 | $9 |
| Omeprazole | 16 | $102 | $6 |
| Prednisone | 30 | $91 | $3 |
| Escitalopram | 16 | $86 | $5 |
| Azithromycin | 11 | $72 | $7 |
| Naproxen | 12 | $51 | $4 |
Money from drug and device companies
$577 in 2025
A payment is not proof that care is biased.
| Novo Nordisk | Rybelsus | $117 | 5 payments
|
| Sage Therapeutics | Zurzuvae | $71 | 3 payments
|
| Lilly USA | Mounjaro | $51 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $51 | 3 payments
|
| Exact Sciences | The Cologuard Plus Collection Kit | $50 | 2 payments
|
| Pfizer | Prevnar 20 | $45 | 2 payments
|
See all 27 published payments
| Sage Therapeutics | Meals · 2025-12-22 | Zurzuvae | $22 |
| Pfizer | Meals · 2025-11-10 | Vyndaqel | $18 |
| Novo Nordisk | Meals · 2025-10-28 | Rybelsus | $26 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-21 | Kerendia | $15 |
| Hologic Sales and Service | Meals · 2025-10-01 | Aptima | $21 |
| Sage Therapeutics | Meals · 2025-09-24 | Zurzuvae | $25 |
| Supernus Pharmaceuticals | Meals · 2025-09-24 | Qelbree | $25 |
| Exact Sciences | Meals · 2025-09-17 | The Cologuard Plus Collection Kit | $27 |
| Sage Therapeutics | Meals · 2025-08-06 | Zurzuvae | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-24 | Kerendia | $15 |
| Novo Nordisk | Meals · 2025-07-16 | Rybelsus | $24 |
| Lilly USA | Meals · 2025-06-20 | Mounjaro | $17 |
| Amneal Pharmaceuticals | Meals · 2025-06-16 | Crexont | $16 |
| Novo Nordisk | Meals · 2025-06-11 | Rybelsus | $24 |
| Paratek Pharmaceuticals | Meals · 2025-06-02 | Nuzyra | $15 |
| Alkermes | Meals · 2025-05-27 | Vivitrol | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-05-15 | Rexulti | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-01 | Breztri | $18 |
| Novo Nordisk | Meals · 2025-04-23 | Ozempic | $22 |
| Lilly USA | Meals · 2025-04-04 | Mounjaro | $18 |
| Exact Sciences | Meals · 2025-03-20 | Cologuard Collection Kit | $23 |
| Pfizer | Meals · 2025-03-19 | Prevnar 20 | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-06 | Kerendia | $20 |
| Novo Nordisk | Meals · 2025-02-26 | Ozempic | $22 |
| Merck Sharp & Dohme | Meals · 2025-02-13 | None | $18 |
| ViiV Healthcare | Meals · 2025-02-10 | Apretude | $33 |
| Lilly USA | Meals · 2025-02-07 | Zepbound | $17 |
Professional record
- NPI
- 1881268159
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 1275 Tharp Rd, Yuba City, CA, 95993
- NPI first listed
- 2021-05-19
- NPI last updated
- 2025-04-11
- NPI record certified
- 2025-04-11
This is when the NPI record was last certified, not a medical board exam.